About Multimeric Biotherapeutics
►"Multimeric" makes medicines that unleash the power of the immune system to treat cancer and serious infections.
► The lead compound is MegaCD40L™, a unique 2-trimer form of CD40 ligand (CD40L), where CD40L is the most powerful immune stimulator made by the body.
► Multimeric's technology is protected by issued patents worldwide.
► The initial clinical program is an immunotherapy for ovarian cancer.
► A second clinical program is MegaOX40L™ as an immunotherapy for prostate cancer and other tumors.
► Multimeric is also advancing an exciting new vaccine platform that uses its technology to generate CD8+ T cell responses strong enough to protect against HIV, influenza, and malaria and capable of having significant anti-tumor effects.
► Separately, Multimeric earns revenues from sales of its unique lab reagents.
